Last reviewed · How we verify
PENTETATE INDIUM DISODIUM IN 111 — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
PENTETATE INDIUM DISODIUM IN 111 (PENTETATE INDIUM DISODIUM IN 111).
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| PENTETATE INDIUM DISODIUM IN 111 TARGET | PENTETATE INDIUM DISODIUM IN 111 | marketed | 1982-01-01 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- PENTETATE INDIUM DISODIUM IN 111 CI watch — RSS
- PENTETATE INDIUM DISODIUM IN 111 CI watch — Atom
- PENTETATE INDIUM DISODIUM IN 111 CI watch — JSON
- PENTETATE INDIUM DISODIUM IN 111 alone — RSS
Cite this brief
Drug Landscape (2026). PENTETATE INDIUM DISODIUM IN 111 — Competitive Intelligence Brief. https://druglandscape.com/ci/pentetate-indium-disodium-in-111. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab